Skip to main content
Log in

Epidemiology of neuromyelitis optica spectrum disorder in Tehran, Iran: the prevalence, baseline characteristics, and clinical aspects

  • Letter to the Editor
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Etemadifar, M., et al., Epidemiology of neuromyelitis optica in the world: a systematic review and meta-analysis. Mult Scler Int, 2015. 2015

  2. Eskandarieh S, Nedjat S, Azimi AR, Moghadasi AN, Sahraian MA (2017) Neuromyelitis optica spectrum disorders in Iran. Mult Scler Relat Disord 18:209–212

    Article  Google Scholar 

  3. Wingerchuk, D.M., et al., International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology, 2015. 85(2): p. 177–189

  4. Eskandarieh, S., et al., Environmental risk factors in neuromyelitis optica spectrum disorder: a case–control study. Acta Neurol Belg, 2018. 118(2): p. 277–287

  5. Ashtari, F., et al., Neuromyelitis optica spectrum disease characteristics in Isfahan, Iran: a cross-sectional study. J Res Med, 2017. 22

  6. Papp, V., et al., Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark. Neurology, 2018. 91(24): p. e2265-e2275

  7. Kashipazha, D., et al., A descriptive study of prevalence, clinical features and other findings of neuromyelitis optica and neuromyelitis optica spectrum disorder in Khuzestan Province, Iran Iran J Neurol, 2015. 14(4): p. 204–210

Download references

Acknowledgments

The authors appreciate Dr. Beladimoghadam N. and the staffs of the Multiple Sclerosis Research Center for their sincere cooperation.

Funding

This study was financially supported by the Tehran University of medical sciences.

Author information

Authors and Affiliations

Authors

Contributions

N.R: Data collection and drafting of the manuscript. M.A.S: Data collection and drafting of the manuscript. A.N.M: Data collection and drafting of the manuscript. SH.E: Hypothesis, methodology, analysis, and drafting of the manuscript.

Corresponding author

Correspondence to Sharareh Eskandarieh.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

The study protocol was approved at the ethics committee of Tehran University of medical sciences by IRB code of “IR.TUMS.NI.REC.1398.047.”

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rezaeimanesh, N., Sahraian, M.A., Moghadasi, A.N. et al. Epidemiology of neuromyelitis optica spectrum disorder in Tehran, Iran: the prevalence, baseline characteristics, and clinical aspects. Neurol Sci 41, 2647–2648 (2020). https://doi.org/10.1007/s10072-020-04393-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-020-04393-7

Navigation